Previous 10 | Next 10 |
VolitionRx Limited Schedules Third Quarter 2023 Earnings Conference Call and Business Update PR Newswire Conference call to take place on Wednesday November 15 at 8:30 a.m. U.S Eastern Time HENDERSON, Nev. , Nov. 8, 2023 /PRNewswire/ -- VolitionRx...
Volition Presents Breakthrough Liquid Biopsy Blood Test Method for Early-stage Cancer PR Newswire HENDERSON, Nev. , Oct. 23, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has unveiled what it bel...
Measuring Nucleosomes Using Nu.Q® NETs is a Promising Biomarker for Septic Shock PR Newswire HENDERSON, Nev. , Oct. 19, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the publicatio...
US Ambassador Adler visits Belgian Volition PR Newswire HENDERSON, Nev. , Oct. 18, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, welcomed Ambassador Michael M. Adler , U.S. Ambassador to...
Volition Presents Three Cancer Detection Abstracts at ESMO 2023 PR Newswire HENDERSON, Nev. , Oct. 16, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is presenting three scientific abstracts a...
Volition Publishes Key Opinion Leader Roundtable Report on NETs in Sepsis PR Newswire HENDERSON, Nev. , Oct. 13, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has published a report summarisi...
Volition to Reveal New Cancer Detection Method Insights at Upcoming Webinar PR Newswire HENDERSON, Nev. , Oct. 2, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is taking part in a webinar ho...
2023-09-22 12:52:13 ET For further details see: CETX, MYO and MORF among mid-day movers
2023-09-22 09:59:56 ET More on Health Care Select Sector SPDR BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.5395 BofA clients were net buyers of U.S. equities for a fifth consecuti...
Volition Hosts Key Opinion Leader Roundtable on Sepsis Management PR Newswire HENDERSON, Nev. , Sept. 13, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is hosting a Key Opinion Leader ("KOL"...
News, Short Squeeze, Breakout and More Instantly...
VolitionRX Limited Company Name:
VNRX Stock Symbol:
NYSE Market:
VolitionRx Limited Announces First Quarter 2024 Financial Results and Business Update PR Newswire Conference call to discuss financial and operational results scheduled for Tuesday, May 14 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev. , May 1...
VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update PR Newswire Conference call to take place on Tuesday May 14 at 8:30 a.m. U.S Eastern Time HENDERSON, Nev. , May 8, 2024 /PRNewswire/ -- VolitionRx Limite...
VolitionRx (NYSE American: VNRX) is a multi-national company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. ...